AlphAIalphai — Financial news for AI agents
investing.comSEP 22 min read$LFST

Lifestance Health Group stock hits 52-week high at $12.97

Lifestance Health Group (LFST) stock hit a 52-week high at $12.97, now trading at $13 with a $4.81B market cap. The stock surged 129.51% over the past year, driven by strong Q2 2026 earnings and raised full-year outlook. Revenue grew 26% to $435.35M, with adjusted EBITDA up 94% to $66M, according to the company.

Original reporting
investing.com
Published Sep 2, 2026, 1:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 5:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$LFST
Bullish
high confidence
Mentioned
$LFST
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$LFSTBullishHigh
01

Why it matters

Earnings beat supports a bullish stance; price may test resistance near $14.

02

Market read

Strong earnings lift LFST and may positively influence related healthcare stocks.

03

What to watch

Potential reimbursement headwinds and competitive pressures in behavioral health.

Relevance 8/10Novelty 8/10Timing: today

Background

LFST reported Q2 2026 results, beating consensus and raising guidance amid rising visit volumes.

Company-level read

Ticker impact

$LFSTBullishHigh confidence
Context

Q2 2026 earnings beat expectations with adjusted EPS $0.06 and revenue $435.35M, raising full-year outlook.

Expected impact

upward pressure on LFST price in the short term

Evidence & confidence

Revenue and EPS beat, higher guidance and strong EBITDA growth suggest continued momentum.

Market effects

Sector

Positive earnings may lift broader mental‑health and outpatient care stocks.

Regional

U.S. healthcare sector gains modestly.

Global

Limited to U.S. markets; no global ripple.

Counterpoint

What could challenge this read

Valuation appears stretched; PEG 0.23 may not reflect future margin pressure.

Key entities

  • company
    LifeStance Health Group Inc.

    U.S. outpatient mental‑health provider.

Read at source← All news

Related articles

AUG 8
$LFSTMedAI 8/10

LifeStance Health Group, Inc. Q2 2026 Earnings Call Summary

LifeStance Health Group reported Q2 2026 revenue growth of 26%, driven by higher visit volumes and a 6% rise in revenue per visit, and said visits per clinician rose 7% YoY. The company raised full-year 2026 guidance to $1.685B-$1.725B revenue and 13.2% adjusted EBITDA margins, approved a new $100M buyback, and reported Q2 free cash flow of $88M.

yahoo.com7 min
AUG 7
$LFSTHighAI 9/10

LifeStance (LFST) Q2 2026 Earnings Call Transcript

LifeStance (LFST) reported Q2 2026 results on an earnings call. Revenue rose to $435 million (+26%) on 2.6 million visits (+19%) and total revenue per visit of $167 (+6%). Adjusted EBITDA was $66 million (+94%) with a 15.2% margin. Full-year 2026 revenue guidance was raised to $1.685-$1.725 billion and adjusted EBITDA to $215-$235 million.

fool.com6 min
AUG 6
$LFSTMedAI 8/10

LifeStance Health: Q2 Earnings Snapshot

LifeStance Health Group Inc. (LFST) reported Q2 net income of $23.6 million, or 6 cents per share, topping Wall Street expectations. Revenue was $435.4 million versus an expected $414.3 million, according to Zacks Investment Research. For the quarter ending September, the company forecast revenue of $420 million to $440 million, and full-year revenue of $1.69 billion to $1.73 billion.

yumasun.com2 min
AUG 6
$LFSTHigh

LifeStance Health Group, Inc. (LFST): Results of Operations and Financial Condition

LifeStance Health Group, Inc. (LFST) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 investor.relations@lifestance.com LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook Announces $100 Million Share Repurchase Program S

SEC EDGAR 8-K6 min